Executive Summary
This digest of 10 high-value federal grants, totaling $1.85 billion, reveals a heavily civilian-dominated procurement landscape (9 of 10 awards), with the Department of Health and Human Services (HHS) as the most active agency across four awards worth $470M+.
The sole defense-related contract is a $452M GSA FEDSIM R&D award to MANTECH, which provides multi-year revenue visibility but carries standard cost-reimbursement risk. The highest-conviction signal is a bullish $133.5M firm-fixed-price award to Partner Therapeutics for Leukine, a pharmaceutical preparedness product, indicating strong HHS/ASPR demand for medical countermeasures. A key risk is the concentration of civilian agency IT and consulting contracts (e.g., SAIC, Peraton, MAXIMUS) that may face budget pressure under a Continuing Resolution, particularly for non-essential modernization work.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from June 05, 2026.
Investment Signals (4)
- Partner Therapeutics Wins $133.5M HHS Firm-Fixed-Price Award for Leukine (HIGH)▲
Partner Therapeutics, a small business, secured a $133.5M firm-fixed-price delivery order from HHS/ASPR for Leukine, a pharmaceutical preparation, with $83.5M already outlaid. This signals strong government demand for medical preparedness products and provides high revenue visibility through March 2027.
- MANTECH Wins $452M GSA FEDSIM R&D Contract – Multi-Year Revenue Visibility (MEDIUM)▲
MANTECH secured a $452M cost-plus-fixed-fee contract for R&D services through 2027, providing ~$60M annual revenue. The full-and-open competition win signals strong competitive standing in defense and civilian R&D markets.
- MAXIMUS Federal Services Wins $94.1M IRS IT Modernization Contract (MEDIUM)▲
MAXIMUS won a $94.1M firm-fixed-price BPA call from the IRS for IT systems integration, with only $30.6M outlaid so far. Option exercises could increase the contract value and signal sustained IRS IT spending.
- SAIC's $290.8M GSA Contract Ended in 2022 with Negative Outlay – No Current Revenue Impact (HIGH)▲
SAIC's $290.8M cost-plus award fee contract with GSA for EPA end user support ended in September 2022, with a negative outlay of -$1.4M. This contract provides no forward revenue visibility and may indicate past underperformance.
Risk Flags (3)
- Execution [HIGH RISK]▼
CADDELL CONSTRUCTION's $322.4M firm-fixed-price contract for the Rio New Consulate Compound carries execution risk due to fixed-price pricing and the complexity of international construction. Cost overruns could materially impact margins.
- Budget [MEDIUM RISK]▼
Multiple civilian agency IT contracts (MAXIMUS IRS, Peraton GSA, CTIS NIH) may face funding delays or cuts under a Continuing Resolution, particularly for non-essential modernization work. The IRS contract has only $30.6M outlaid of $92.3M total obligation.
- Concentration [MEDIUM RISK]▼
HHS accounts for 4 of 10 contracts totaling $470M+, creating concentration risk for investors exposed to HHS-dependent contractors. Any HHS budget cuts or policy shifts would disproportionately affect these firms.
Opportunities (3)
- ◆
MANTECH's $452M GSA FEDSIM R&D contract through 2027 positions the company for follow-on defense and civilian R&D awards. Investors should watch for additional task orders under this IDIQ vehicle.
- ◆
MAXIMUS's $94.1M IRS IT modernization contract could expand if options are exercised. The IRS's push for digital transformation and tax administration modernization supports follow-on work.
- ◆
JAG KETCHIKAN, a small business, won a $99.6M NOAA ship modernization contract under full-and-open competition. This demonstrates small business competitiveness in maritime infrastructure and could lead to similar NOAA awards.
Sector Themes (2)
- ◆
Contracts to MAXIMUS ($94.1M IRS), Peraton ($121.6M GSA), and CTIS ($85.6M NIH) show sustained demand for IT application development and modernization across civilian agencies. However, low outlay rates on some contracts (e.g., MAXIMUS at 33%) signal potential budget constraints.
- ◆
Partner Therapeutics' $133.5M HHS/ASPR award for Leukine underscores government focus on medical countermeasures. This is a high-conviction, firm-fixed-price contract with strong outlay (62.5%), indicating reliable funding.
Watch List (3)
- 👁
{"entity"=>"MANTECH INTERNATIONAL CORPORATION", "reason"=>"Won $452M GSA FEDSIM R&D contract through 2027; watch for additional task orders and revenue contribution in quarterly filings.", "trigger"=>"Quarterly earnings reports mentioning this contract; new GSA FEDSIM R&D awards"}
- 👁
{"entity"=>"MAXIMUS FEDERAL SERVICES, INC.", "reason"=>"IRS contract has low outlay ($30.6M of $92.3M); option exercises would signal sustained demand.", "trigger"=>"Option exercise announcements; IRS IT budget updates"}
- 👁
{"entity"=>"JAG KETCHIKAN, LLC", "reason"=>"Won $99.6M NOAA ship modernization; execution on firm-fixed-price contract is key.", "trigger"=>"Progress reports on NOAA Ship Henry B. Bigelow; future NOAA solicitations"}
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 10 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: High-Value Federal Grants ($5M+)
🇺🇸 More from United States
View all →June 05, 2026
US Pre-Market SEC Filings Roundup — June 05, 2026
US Pre-Market SEC Filings Roundup
June 05, 2026
S&P 500 Technology Sector SEC Filings — June 05, 2026
S&P 500 Technology Sector SEC Filings
June 05, 2026
Global High-Priority Regulatory Events — June 05, 2026
Global High-Priority Regulatory Events
June 05, 2026
All NASA Contracts — June 05, 2026
All NASA Contracts